Note: Ingredients listed on restricted chemical lists
EC/CAS
67-56-1
Name of the chemical
Methanol
Concentration
N/A
EC/CAS
200-659-6
Name of the chemical
Methanol
Concentration
N/A
General Information
Revision date
2021-04-21
Product name
SILASTIC RTV-3081-R Mould-Making Curing
1.2.1 Relevant identified uses
Polymer Vulcanising agents Curing agent
Emergency telephone
0031 115 694 982
Icons in SDS
Company Information
company name
DOW CHEMICAL COMPANY LIMITED
e-mail address of the competent person responsible for the Safety Data Sheet
SDSQuestion@dow.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H373
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
CLP CLASSIFICATION
Skin sensitisation - Category 1 - H317 Specific target organ toxicity - repeated exposure - Category 2 - Oral - H373 For the full text of the H-Statements mentioned in this Section, see Section 16. ® ™ Trademark of The Dow Chemical Company ("Dow") or an affiliated
2.2 Label elements
Labelling according to Regulation (EC) No 1272/2008:
Hazard statements
H317 May cause an allergic skin reaction. H373 May cause damage to organs (Bladder, Kidney) through prolonged or repeated exposure if swallowed.
Precautionary statements
P260 Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. P280 Wear protective gloves. P314 Get medical advice/ attention if you feel unwell. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P362 + P364 Take off contaminated clothing and wash it before reuse. P501 Dispose of contents and/or container to an approved waste disposal plant.
Contains
Trimethoxyphenylsilane; Bis[(2-ethyl-2,5-dimethylhexanoyl)oxy](dimethyl)stannane
2.3 Other hazards
This product contains no substances assessed to be PBT or vPvB at levels of 0.1% or higher. Endocrine disrupting properties
Environmental hazards
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. Human Health: The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.